The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment
Abstract
OBJECTIVE: Type 2 diabetes is a slowly progressive disease, in which the gradual deterioration of glucose tolerance is associated with the progressive decrease in β-cell function. Hyperglycemia per se has deleterious effects on both beta-cell function and insulin action, which are partially reversible by the short-term control of blood glucose levels. We hypothesized that the induction of euglycemia, using intensive insulin therapy at the time of clinical diagnosis, could lead to a significant improvement in insulin secretion and action and thus alter the clinical course of the disease. RESEARCH DESIGN AND METHODS: Thirteen newly diagnosed diet-unresponsive type 2 diabetic patients were treated with continuous subcutaneous insulin infusion (CSII) for 2 weeks and followed longitudinally while being treated with diet alone. RESULTS: Four patients were considered therapeutic failures since CSII failed to induce euglycemia (n = 1) or glucose control deteriorated within 6 months after CSII (n = 3). The remaining nine patients were maintained on diet alone with adequate control from 9 to > 50 months (median ± SE, 26 ± 4.8 months). In five patients, glycemic control deteriorated after 9–36 months, but a repeat 2-week CSII treatment reestablished control in four patients. One of these patients underwent a third CSII treatment 13 months later. At the time this article was written, six patients of the initial group were still controlled without medication 16–59 months (median ± SE, 45.5 ± 6.6 months) after the initiation of treatment. Body weight remained unchanged in all patients. CONCLUSIONS: These findings suggest that in a significant proportion of type 2 diabetic patients who fail to respond to dietary measures, short-term intensive insulin treatment can effectively establish responsiveness, allowing long-term glycemic control without medication. Further studies are required to establish whether simpler treatment regimens could be equally effective. If the hypothesis offered here finds support, present approaches to the management of newly diagnosed type 2 diabetes may need to be revised.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mounting evidence suggests that aggressive lowering of glycemia, especially with insulin therapy, in newly diagnosed diabetes can result in sustained remissions, i.e., normoglycemia without need for glucose-lowering medications (87,88).”
From Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) · cites this paper as [87]
Citations
Cites
Nonketotic diabetes mellitus: Insulin deficiency or insulin resistance?
Reaven, G. M., Bernstein, R., Davis, B. M., & Olefsky, J. M. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90536-2 · Cited by 356
Leahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 289
Glibenclamide-associated hypoglycaemia: A report on 57 cases
Asplund, K., Wiholm, B. ‐., & Lithner, F. (1983) · Diabetologia · doi:10.1007/bf00257338 · Cited by 255
Basal and 24-h C-peptide and insulin secretion rate in normal man
Kruszynska, Y. T., Home, P., Hanning, I., & Alberti, K. G. M. M. (1987) · Diabetologia · doi:10.1007/bf01788901 · Cited by 119
Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?
Leibowitz, G., & Cerasi, E. (1996) · Diabetologia · doi:10.1007/bf00403296 · Cited by 106
Self-citationVuorinen-Markkola, H., Koivisto, V. A., & Yki‐Järvinen, H. (1992) · Diabetes · doi:10.2337/diab.41.5.571 · Cited by 104
Gläser, B., Leibovitch, G., Nesher, R., HARTLING, S. G., Binder, C., & Cerasi, E. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1180365 · Cited by 94
Self-citationInsulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?
Cerasi, E. (1995) · Diabetologia · doi:10.1007/bf00400591 · Cited by 77
Self-citationLong-Term Normoglycemic Remission in Black Newly Diagnosed NIDDM Subjects
Banerji, M. A., Chaiken, R. L., & Lebovitz, H. E. (1996) · Diabetes · doi:10.2337/diab.45.3.337 · Cited by 67
Yki-Järvinen, H., Esko, N., Helve, E., & Taskinen, M. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90412-3 · Cited by 50
Cited by
Sorted by citations
Items 201–269 of 269
The Importance of Early Insulin Adoption in Type 2 Diabetes Management
(2009) · The Internet Journal of Family Practice · doi:10.5580/861 · Cited by 3
Enkaku, A., Chujo, D., Kamigishi, M., Inagawa, S., MATSUKOSHI, S., Sakai, W., Takikawa, A., Fujisaka, S., & Tobe, K. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14129 · Cited by 3
Hanefeld, M., Fleischmann, H., Liebl, A., & Siegmund, T. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0820-1665 · Cited by 3
Assessment of beta cell function in subjects with newly diagnosed type 2 diabetes
Cernea, S., Huţanu, A., Coroş, L., & Dobreanu, M. (2013) · Revista română de medicină de laborator · doi:10.2478/rrlm-2013-0011 · Cited by 3
Emery, A., Ye, C., Choi, H., Kramer, C. K., Zinman, B., & Retnakaran, R. R. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0111 · Cited by 3
CSII in type 2 diabetic patients
Attali, J. R. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(06)70012-2 · Cited by 3
Improvement in severe insulin resistance with frequent injections of lispro insulin.
Raine, C. H., Krzyston, M. J., Amr, M., & Hydrick, L. (1999) · PubMed Central · Cited by 3
Unlocking the Potential of Type 2 Diabetes Mellitus Remission
Sharma, P., & Chakole, S. V. (2023) · Cureus · doi:10.7759/cureus.48704 · Cited by 3
Tratamiento de la diabetes mellitus tipo 2 a partir de las directrices de práctica clínica
Ahluwalia, R., & Vora, J. P. (2010) · Medicina Clínica · doi:10.1016/s0025-7753(10)70027-0 · Cited by 2
Long-Term Intensive Insulin Therapy for Japanese Patients with Type 2 Diabetes Mellitus
Umezono, T., Toyoda, M., Abe, M., Kobayashi, K., Kato, M., Miyauchi, M., Kobayashi, T., Yamamoto, N., Kimura, M., Yagame, M., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1353 · Cited by 2
Management of Type 2 Diabetes Mellitus with Basal-Prandial Insulin Therapy: A Case-Based Review
Davis, S. N. (2007) · Insulin · doi:10.1016/s1557-0843(07)80040-6 · Cited by 2
Interaction Between Exogenous Insulin, Endogenous Insulin, and Glucose in Type 2 Diabetes Patients
Janukonyté, J., Parkner, T., Bruun, N. H., Lauritzen, T., Christiansen, J. S., & Laursen, T. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0326 · Cited by 2
Optimal glucose control in type 2 diabetes mellitus—a guide for the family practitioner
Zyl, D. G. V. (2006) · South African Family Practice · doi:10.1080/20786204.2006.10873481 · Cited by 2
Early use of insulin for beta cell preservation.
Kumar, A. (2007) · PubMed · Cited by 2
Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy
Schmidt, S. C., Huey, M. A., & Whitley, H. P. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.1.50 · Cited by 2
Ou, Q., Cen, C., Fan, C., Lü, L., Wang, F., Chen, C., Mo, Z., Liu, H., Fang, T., Quan, H., et al. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3584 · Cited by 2
Reviewing the evidence: Feline diabetic remission
Bjørnvad, C. R., & Jessen, L. R. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.11.007 · Cited by 2
Clinical Approaches to Preserving β-Cell Function in Diabetes
WAJCHENBERG, B. L., & de Carvalho, R. M. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_17 · Cited by 1
Tip 2 diabetes mellitusta insülin tedavisi
ATMACA, M. H. (2012) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.s1.009 · Cited by 1
A Practical Scheme for the Initial Out-Patient Management of Type-2 Diabetes Mellitus
Udezue, E. O. (2003) · Tropical Doctor · doi:10.1177/004947550303300109 · Cited by 1
Tidlig insulinbehandling ved type 2-diabetes?
Birkeland, K. I. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0866 · Cited by 1
Combination Tratment of Oral Agents and Insulin in Type 2 Diabetes: A Narrative Review
(2016) · International Journal of Diabetes & Metabolic Disorders · doi:10.33140/ijdmd/00004 · Cited by 1
Early Insulin Initiation—A Review of the Literature and Case Studies
(2012) · The Internet Journal of Family Practice · doi:10.5580/2a69 · Cited by 1
Masset, C., Branchereau, J., Karam, G., Hourmant, M., Dantal, J., Giral, M., Garandeau, C., Meurette, A., Kerleau, C., Kervella, D., et al. (2021) · Transplant International · doi:10.1111/tri.13866 · Cited by 1
Progressive elements in type 2 diabetes, studies on secondary failure and diabetic complications
Kärvestedt, L. (2008) · Figshare · Cited by 1
Treatment of Type 2 Using Insulin
Rosenstock, J., & Owens, D. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-572-5_5 · Cited by 1
Kumar, D., Luna-Lollie, T., & Madha, S. (2001) · Endocrine Practice · doi:10.4158/ep.7.4.256 · Cited by 1
How to start insulin treatment: Earlier or delayed insulin therapy
Akalın, S. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.008 · Cited by 1
Dauer der medikamentenfreien Remission bei Patienten mit neu diagnostiziertem Typ-2-Diabetes
Jecht, M. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0904-3
Does insulin preserve β‐cell function in type 2 diabetes?
Heise, T., & Sawicki, P. T. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00965.x
Yakubovich, N. (2012) · MacSphere (McMaster University) · doi:10.71548/20534
Feline diabetic remission: what is the recipe?
Gostelow, R., & Niessen, S. (2015) · Companion animal · doi:10.12968/coan.2015.20.6.340
エキセナチド単独投与後の低血糖をCGM(Continuous glucose monitoring)にて観察しえた2型糖尿病の1例
芳治, 徳., 葉子, 柳., & 俊治, 石. (2013) · 糖尿病 · doi:10.11213/tonyobyo.56.81
Recomendaciones para el empleo de antidiabéticos orales en la diabetes tipo 2
Rey, M. V. R., Gutiérrez, J. M. Á., Lucas, E. G., & García, J. J. L. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70435-3
Agarwal, S. K., Singh, B. K., & Wadhwa, R. (2014) · Indian Journal of Medical Specialities · doi:10.7713/ijms.2014.0002
López-Cortés, L. E., Morales, C., Dorado, J. S., Montes, J. O., & Peña, I. F. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)63011-6
Diabetes prevention in high-risk women with gestational diabetes
Banerji, M. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0060-7
Management Strategies for Diabetes
Ahluwalia, R. (2012) · doi:10.1007/978-1-908517-81-4_2
Insulin Therapy and Clinical Inertia: the Costs for Patients and health systems
Gleeson, J. M., & Gordon, D. (2011)
Cernea, S., Hu, A., Coroş, L., & Dobreanu, M. (2013)
Emergency treatment of hyperglycaemia in adult type-2 diabetic patients in primary care settings
Udezue, E. O. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497554
Wang, D., Sun, L., Song, G., & Chen, S. (2015)
Diabetes in China 3 Early therapy for type 2 diabetes in China
Yang, W., & Key, G. P. (2014)
Review Article Combination Therapy in Diabetes: Review
Joshi, R., & Mukhopadhyay, S. (2014)
Insulinothérapie dans le diabète de type2
Molines, L., Darmon, P., Jannot-Lamotte, M.-F., Schaepelynck, P., Tréglia, C., & Raccah, D. (2013) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(13)56365-7
Journal of Experimental and Clinical Medicine Deneysel ve Klinik Tip Dergisi
Okuyucu, A., Bedir, A., Özmen, Z. C., & Biyokimya, T. D. H. (2012)
Сахарный диабет 2 типа: время изменить концепцию
Russian Federation (2013)
Effects of insulin gene dosage on body weight and glucose homeostasis
Mehran, A. E. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0167270
Bariatric Surgery in Obesity and Reversal of Metabolic Disorders
Manco, M. (2007) · CRC Press eBooks · doi:10.1201/9781420005479.pt8
Clinical Approaches to Preserving b-Cell Function in Diabetes 33
WAJCHENBERG, B. L., & de Carvalho, R. M. (2015)
Development and evaluation of a novel insulin analogue
Khedkar, A. (2015)
Short‐Term Intensive Insulin Therapy in Patients with Newly Presenting Type 2 Diabetes
Xu, W., Owens, D. R., & Weng, J. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch33
Azar, S. T., & Dey, D. (2016) · International Journal of Pharma Research and Health Sciences · doi:10.21276/ijprhs.2016.05.03
MERCADO-ASIS, L. B., Tanchee-Ngo, M. J., Mendoza, E., Mane, A., Vasam, A., Shah, A., & Jain, R. (2019) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2019-0010
Liu, F., Sun, M.-H., Zhao, J., Yang, M., Zhou, X., Zhang, Z., Dong, J., & Liao, L. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1128-6957
Wolmarans, D. W., Steyn, S. F., & Brand, L. (2020) · South African General Practitioner · doi:10.36303/sagp.2020.3.0024
Clinical Approaches to Preserving β-Cell Function in Diabetes
WAJCHENBERG, B. L., & de Carvalho, R. M. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_17-3
Insulin Therapy in Type 2 Diabetes
Wyne, K. L., & Mora, P. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-15
Grigg, A., Thommasen, H. V., Tildesley, H. D., & Michalos, A. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-51161-0_6
Sreemantula, G. (2012) · doi:10.1007/978-1-908517-81-4_3
Lin, M. H., Wang, H., & Qian, Y. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01089-w
曾, 宪. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125582
Erklärtes Ziel: Remission des Typ-2-Diabetes
Kempf, K., & Röhling, M. (2023) · Info Diabetologie · doi:10.1007/s15034-023-4536-z
Other Considerations in Pump Therapy Management
(2024) · American Diabetes Association eBooks · doi:10.2337/9781580408363.ch07
Khan, A. A., Ata, F., Aziz, A., Qassim, A. J., Shukri, A., Aboujabal, K., Almohtasib, Y. S., Jayyousi, A., Bashir, M., & Surchi, H. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70069
Human β‐Cell Dedifferentiation and Diabetes
Sun, J., Son, J., & Wang, Q. (2026) · Journal of Diabetes · doi:10.1111/1753-0407.70280
Insulin therapy at onset of type 2 diabetes mellitus--a new concept.
Sahay, B. K. (2011) · PubMed
Metadata
- Authors
- Ilkova, H., Glaser, B., Tunçkale, A., Bagriaçik, N., & Cerasi, E.
- Affiliations
- Istanbul University-Cerrahpaşa (TR)
- Department of Endocrinology and Metabolism, Hebrew University Hadassah Medical Center Jerusalem, Israel
- Department of Internal Medicine, Division of Metabolism and Diabetes, Istanbul University Cerrahpasa Medical Faculty Istanbul, Turkey
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1997-09-01
- Volume
- 20
- Issue
- 9
- Pages
- 1353-1356
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2094434238
- Cited by
- 269
- References
- 13
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 12 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 7 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 18 · 2012: 19
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, newly diagnosed diabetes, intensive insulin therapy, insulin pump therapy, glycemic control, beta-cell function, insulin secretion, insulin action
- MeSH terms
- Adult, Aged, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Infusion Pumps, Insulin, Male, Middle Aged, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review